These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7594815

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Enhancement of the response of B16F1 melanoma to fractionated radiotherapy and prolongation of survival by withaferin A and/or hyperthermia.
    Kalthur G, Pathirissery UD.
    Integr Cancer Ther; 2010 Dec; 9(4):370-7. PubMed ID: 20713375
    [Abstract] [Full Text] [Related]

  • 23. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
    Di Cosimo S, Ferretti G, Papaldo P, Carlini P, Fabi A, Cognetti F.
    Drugs Today (Barc); 2003 Mar; 39(3):157-74. PubMed ID: 12730701
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Influence of 5-hydroxytryptamine on the combination effect of lonidamine or gossypol and hyperthermia on Ehrlich tumour in vivo.
    Molla MR, Yoshiga K, Takada K.
    Anticancer Res; 1987 Mar; 7(3 Pt B):361-4. PubMed ID: 3631888
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic outcome and side-effects after radiotherapy, chemotherapy and/or hyperthermia treatment of head and neck tumour xenografts.
    Ressel A, Schmitt O, Weiss C, Feyerabend T.
    Eur J Cancer; 2002 Mar; 38(4):594-601. PubMed ID: 11872355
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
    Hokland SL, Horsman MR.
    Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
    [Abstract] [Full Text] [Related]

  • 29. The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma.
    Haas GP, Klugo RC, Hetzel FW, Barton EE, Cerny JC.
    J Urol; 1984 Oct; 132(4):828-33. PubMed ID: 6540817
    [Abstract] [Full Text] [Related]

  • 30. Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma.
    Jones E, Alvarez Secord A, Prosnitz LR, Samulski TV, Oleson JR, Berchuck A, Clarke-Pearson D, Soper J, Dewhirst MW, Vujaskovic Z.
    Int J Hyperthermia; 2006 Mar; 22(2):161-72. PubMed ID: 16754599
    [Abstract] [Full Text] [Related]

  • 31. Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
    Tanaka J, Teicher BA, Herman TS, Holden SA, Dezube B, Frei E.
    Int J Cancer; 1991 Jun 19; 48(4):631-7. PubMed ID: 2045206
    [Abstract] [Full Text] [Related]

  • 32. Effects of pre-heating on cis-diamminedichloroplatinum(II)-hyperthermia-induced tumour growth depression of transplantable human oesophageal cancer to nude mice.
    Yano T, Nakatani K, Watanabe A, Nakano H, Ohnishi T.
    Int J Hyperthermia; 1993 Jun 19; 9(5):699-708. PubMed ID: 8245581
    [Abstract] [Full Text] [Related]

  • 33. Radiotherapy plus lonidamine in non-small cell lung cancer.
    Cionini L.
    Semin Oncol; 1991 Apr 19; 18(2 Suppl 4):49-52. PubMed ID: 1851578
    [Abstract] [Full Text] [Related]

  • 34. Summary of studies adding systemic chemotherapy to local hyperthermia and radiation.
    Herman TS, Teicher BA.
    Int J Hyperthermia; 1994 Apr 19; 10(3):443-9. PubMed ID: 7930812
    [Abstract] [Full Text] [Related]

  • 35. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 36. The Role of Hyperthermia in Potentiation of Anti-Angiogenic Effect of Cisplatin and Resveratrol in Mice Bearing Solid Form of Ehrlich Ascites Tumour.
    Kučan D, Oršolić N, Odeh D, Ramić S, Jakopović B, Knežević J, Jazvinšćak Jembrek M.
    Int J Mol Sci; 2023 Jul 04; 24(13):. PubMed ID: 37446252
    [Abstract] [Full Text] [Related]

  • 37. Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer.
    Keene KS, Harman EM, Knauf DG, McCarley D, Zlotecki RA.
    Am J Clin Oncol; 2005 Jun 04; 28(3):217-22. PubMed ID: 15923791
    [Abstract] [Full Text] [Related]

  • 38. Response of mouse sarcoma-180 to cis-platin in combination with radiation & hyperthermia.
    Rao BS, Devi PU.
    Indian J Med Res; 1996 Jun 04; 103():315-22. PubMed ID: 8707373
    [Abstract] [Full Text] [Related]

  • 39. Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment.
    Petryk AA, Giustini AJ, Gottesman RE, Kaufman PA, Hoopes PJ.
    Int J Hyperthermia; 2013 Dec 04; 29(8):845-51. PubMed ID: 24144336
    [Abstract] [Full Text] [Related]

  • 40. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
    Teicher BA, Williams JI, Takeuchi H, Ara G, Herbst RS, Buxton D.
    Anticancer Res; 1998 Dec 04; 18(4A):2567-73. PubMed ID: 9703911
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.